Mira Pharmaceuticals MIRA
NASDAQ MIRA
$0.63 -0.05 (-7.35%)
At close: Oct 22, 2026 · 4:00 PM EDT

Mira Pharmaceuticals (MIRA) Short term Debt (2022 - 2023)

Updated

Mira Pharmaceuticals (MIRA) recorded Short term Debt of $1.8 million in the quarter ended Jun 30, 2023.

Analysis

Mira Pharmaceuticals (MIRA) Short term Debt (2022 - 2023) Analysis & Trends

As of Dec 31, 2022, Mira Pharmaceuticals reported Short term Debt of $133,062.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Mira Pharmaceuticals 14.93 Mn -5.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 1.80 Mn
Dec 31, 2022 133,062.00
API Access

Mira Pharmaceuticals Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=MIRA&period=max&api_key=YOUR_API_KEY